Groupe d'Etude en Oncologie du Quebec

Titre	Liquid biopsy for Non-Small Cell Lung Cancer: comparing plasma cell-free DNA/RNA to tissue NGS to assesses turnaround time, patient distress and cost-effectiveness
Protocole ID	QC-LIQBIOP
ClinicalTrials.gov ID	n.d.
Type(s) de cancer	Poumon non à petites cellules
Phase	Autres
Institution	CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS 3755 rue de la Côte Ste. Catherine, Montréal, QC, H3T 1E2
Ville	Montréal
Investigateur(trice) principal(e)	Dr Jason Agulnik
Coordonnateur(trice)	Goulnar Kasymjanova 514-340-8222 poste 24312
Statut	Actif en recrutement
Critètes d'éligibilité	Patients with suspected advanced non-squamous Non-Small Cell Lung Cancer (NSCLC), Stage III or IV who are eligible for a diagnostic biopsy procedure. No medical contraindications for diagnostic procedure Provide written informed consent in accordance with institutional guidelines.
Critètes d'exclusion	Past medical history of other cancer within the last 3 years Tissue biopsy is not possible for any reason

Groupe d'étude en oncologie du Québec